CUTANEOUS T-CELL LYMPHOMA STAGE II

CUTANEOUS T-CELL LYMPHOMA STAGE II was reported 22 times

CUTANEOUS T-CELL LYMPHOMA STAGE II is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEXAROTENE 2 0.0015
1 ROMIDEPSIN 1 0.0006
2 MECHLORETHAMINE HYDROCHLORIDE 1 0.0004
3 ACITRETIN 2 0.0004
4 DASPONE 2 0.0002
5 DAPSONE GEL, 5% 2 0.0002
6 DAPSONE 2 0.0002
7 FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% 1 0.0002
8 BRENTUXIMAB VEDOTIN 1 0.0001
9 CLOBETASOL PROPIONATE OINTMENT USP, 0.05% 1 0.0001
10 CLOBETASOL PROPIONATE 1 0.0001
11 IXEKIZUMAB 3 0.0001
12 ADALIMUMAB-FKJP 3 0.0001
13 ADALIMUMAB-AATY 3 0.0001
14 ADALIMUMAB-ADAZ 3 0.0001
15 TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% 1 0.0000
16 MYCOPHENOLATE MOFETIL 5 0.0000
17 VINCRISTINE SULFATE 1 0.0000
18 THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE 1 0.0000
19 TRIAMCINOLONE ACETONIDE 1 0.0000
20 UPADACITINIB 2 0.0000
21 LIRAGLUTIDE 1 0.0000
22 CYCLOSPORINE 2 0.0000
23 METHOTREXATE SODIUM 8 0.0000
24 TACROLIMUS OINTMENT 0.1% 2 0.0000
25 TACROLIMUS EXTENDED-RELEASE CAPSULES 2 0.0000
26 DUPILUMAB 8 0.0000
27 DOXYCYCLINE HYCLATE 1 0.0000
28 DOXYCYCLINE 1 0.0000
29 TACROLIMUS 2 0.0000
30 DOXORUBICIN 1 0.0000
31 GABAPENTIN 3 0.0000
32 FOLIC ACID 2 0.0000
33 ABATACEPT 1 0.0000
34 PREDNISONE 3 0.0000
35 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
36 CYCLOPHOSPHAMIDE 1 0.0000
37 RITUXIMAB 1 0.0000
38 ADALIMUMAB 3 0.0000
39 ETANERCEPT 1 0.0000